Clinical Trials
2 trialsNCT07544654 2026-05-27
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Phase 3 Not yet recruiting
NCT01701349 2014-05-01
FACT2
Mateon Therapeutics
Phase 3 Withdrawn